BOOK NOW
  • Episode 128
  • 11/07/2023

Revolutionizing Skincare: Targeting Aging at the Cellular Level ft. Dr. Carolina Reis | Thrive State Podcast

In this episode of the Thrive State Podcast, join host Dr. Kien Vuu as he interviews Dr. Carolina Reis, a renowned scientist and founder of OneSkin, a groundbreaking skincare brand. Discover the cutting-edge research behind their revolutionary peptide, OS-1, which targets and reduces the accumulation of senescent cells in the skin. Learn how this innovative approach can combat aging, promote skin health, and even impact systemic inflammation. Don’t miss this insightful conversation that explores the intersection of science, longevity, and skincare.

"Senescence cells compare with a bad apple in a basket because one senescence cell basically ruins the cells around it and accelerates the aging process." - Dr. Carolina Reis
Share:

Timestamps

0:00
Introduction
1:22
Background on OneSkin and skin aging research
4:45
Understanding senescence cells and their impact on skin aging
7:56
Discovering the OS-1 peptide and its unique properties
10:32
The role of inflammation and skin health
13:47
Clinical studies and results with OS-1
17:09
The complementary ingredients in OneSkin products
19:58
Simplifying skincare routines for effective results
22:05
Exploring the systemic effects of OS-1 and its potential benefits
28:18
The science behind OS-1 and its formulation
30:43
Where to find OneSkin products and stay updated
32:32
Dr. Carolina Reis' best medicine and closing remarks
"Our goal is to offer the most effective solution yet the simplest that you can have to achieve very healthy skin." - Dr. Carolina Reis
Share:

Listen & Subscribe

Get Your Free Copy of
Thrive State

Your Upgrade Starts Now

Get Dr. V’s bestselling book Thrive State delivered straight to your inbox — the science-backed framework that’s transformed leaders at HomeServices, Cotality, and Fortune 500 organizations.

Plus an exclusive resource bundle to upgrade your energy, longevity, and leadership from day one.